The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial

BACKGROUND: Nephropathy in Diabetes type 2 (NID-2) study is an open-label cluster randomized clinical trial that demonstrated that multifactorial intensive treatment reduces Major Adverse Cardiac Events (MACEs) and overall mortality versus standard of care in type 2 diabetic subjects with albuminuri...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasso, Ferdinando Carlo, Simeon, Vittorio, Galiero, Raffaele, Caturano, Alfredo, De Nicola, Luca, Chiodini, Paolo, Rinaldi, Luca, Salvatore, Teresa, Lettieri, Miriam, Nevola, Riccardo, Sardu, Celestino, Docimo, Giovanni, Loffredo, Giuseppe, Marfella, Raffaele, Adinolfi, Luigi Elio, Minutolo, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641842/
https://www.ncbi.nlm.nih.gov/pubmed/36344978
http://dx.doi.org/10.1186/s12933-022-01674-7

Ejemplares similares

Ejemplares similares